COMMUNIQUÉS West-GlobeNewswire

SK pharmteco annonce le succès de l’inspection de son site de fabrication de petites molécules par la FDA, à La Porte, au Texas
17/03/2026
RANCHO CORDOVA, Californie, 17 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui l’issue favorable de l’inspection réglementaire de son site de petites molécules en Amérique du Nord, situé à La Porte, au [...]
Compass Health Invites Community to “Camp Out” for Youth Behavioral Health
17/03/2026
Annual fundraiser supports programs for children, youth, and families across Northwest Washington EVERETT, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- For fifteen years, Compass Health has hosted therapeutic camps that [...]
Naturonel Launches Made-in-USA Herbal Supplements to Support Metabolic Wellness
17/03/2026
New line of plant-based dietary supplements tested for purity and potency now available to consumers nationwide. Naturonel Image PRINCETON, N.J., March 17, 2026 (GLOBE NEWSWIRE) -- Naturonel, a wellness brand focused on [...]
Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025
17/03/2026
Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025. Le Groupe annonce avoir mis à la disposition du public ses comptes consolidés au 31 décembre 2025 sur le site internet du Groupe, à l’adresse [...]
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
17/03/2026
Jails outpace prisons in offering MOUD, but regional disparities and limited treatment access persist across the U.S. Qualitative feedback points to need for greater reentry support, housing, care coordination, and [...]
UPDATE – Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference
17/03/2026
EAGLE, Idaho, March 17, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025
17/03/2026
Public release of Virbac Consolidated Accounts at 31 December 2025. The Group released its 2025 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com, under “Investors”, “ [...]
Virbac: 2025 annual results
17/03/2026
A robust adjusted EBIT margin² of 16.3% at CERS, driven by solid organic revenue growth of 7.9% Solid 2025 dynamic with annual revenue up +7.9% at CERS; with strong momentum in key categories and countries. Volume/mix [...]
Moleculin to Present at 38th Annual ROTH Conference
17/03/2026
– Management to participate in fireside chat presentation with Jonathan Aschoff, Senior Research Analyst at ROTH Capital Partners HOUSTON, March 17, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“ [...]
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
17/03/2026
New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and 12 assays specific to brain [...]
Standard Process Launches SP Children’s® ProSynbiotic
17/03/2026
A Whole Food-Based Synbiotic Designed to Support Digestive Regularity, Gut Balance, and Immune Health in Children PALMYRA, Wis., March 17, 2026 (GLOBE NEWSWIRE) -- Standard Process , a leader in whole food-based [...]
Personalized Keto Made Easy: How Ketoway Supports Consistent Results and Healthy Habits
17/03/2026
Ketoway Helps Users Achieve Lasting Keto Success with Personalized Meal Plans, Guided Workouts, and Transparent Customer Support NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Ketoway is a personalized keto-diet app [...]
SK pharmteco Announces Successful FDA Inspection of Small Molecule Manufacturing Facility in La Porte, Texas
17/03/2026
RANCHO CORDOVA, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced the successful conclusion of a regulatory inspection of its small molecule North America facility in La Porte, Texas. The U.S. Food [...]
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
17/03/2026
Vancouver, Canada, March 17, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non- [...]
Hyperion DeFi Schedules Fourth Quarter and Full Year 2025 Earnings Call for Thursday, March 26 at 8:00 a.m. ET
17/03/2026
LAGUNA HILLS, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed company building a long-term strategic treasury of [...]
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
17/03/2026
PURCHASE, N.Y., March 17, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented [...]
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
17/03/2026
- First ZEVASKYN ® commercial patient treatment completed in December - - ZEVASKYN launch momentum building in first quarter 2026 – - $191.4M in cash, cash equivalents and short-term investments as of December 31, 2025 [...]
ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
17/03/2026
Institutional Financing Interest Emerges for Receivables-Backed Financing Following Extensive Diligence UNIONDALE, NY, March 17, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a [...]
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
17/03/2026
Taipei, Taiwan, March 17, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]

Pages